ATHR

2.7806.71%

AETHER: Q1 FY2027 delivered robust growth, margin expansion, and a landmark Dow Chemical R&D partnership

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Q1 FY2027 saw 27% revenue and 33% PAT growth year-over-year, driven by strong CEM/CRAMS performance and new product launches. Major expansion projects are on track, and a landmark R&D partnership with Dow Chemical positions the company for leadership in advanced silicones and semiconductor materials.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Q1 FY2027 saw 27% revenue and 33% PAT growth year-over-year, driven by strong CEM/CRAMS performance and new product launches. Major expansion projects are on track, and a landmark R&D partnership with Dow Chemical positions the company for leadership in advanced silicones and semiconductor materials.

Based on

Disclaimer
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Login to unlock451characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.